Literature DB >> 10635462

Mouse-chick chimera: an experimental system for study of somite development.

J Fontaine-Pérus1.   

Abstract

As the mammalian embryo is implanted in the uterus and not readily accessible to direct observation or manipulation, much of our understanding of mammalian somite development is based on findings in lower vertebrates. One means of overcoming the difficulties raised by intrauterine development is to engraft mouse tissue in ovo. The experiments described in this chapter relate to the unilateral replacement of somites in chick embryo with those from mouse fetus. Mouse somites differentiate in ovo in dermis, cartilage, and skeletal muscle and are able to migrate into chick host limb. A LacZ transgenic mouse strain was used to ascertain the role of the implanted somites in forming epaxial and hypaxial muscle in the chick embryo. Myogenesis occurred normally in in ovo developing mouse somites, and muscle cells from mouse myotome formed neuromuscular contacts with chick motor axons. After fragments of fetal mouse neural primordium were transplanted into chick embryo, mouse neural tube contributed to the mechanism maintaining myogenesis in the somites of the host embryo. A recently developed double-grafting procedure involving neural tube and somites from knockout mouse strains should elucidate the molecular events involved in early somitogenesis.

Entities:  

Mesh:

Year:  2000        PMID: 10635462     DOI: 10.1016/s0070-2153(08)60759-0

Source DB:  PubMed          Journal:  Curr Top Dev Biol        ISSN: 0070-2153            Impact factor:   4.897


  2 in total

Review 1.  Vertebral body integrity: a review of various anatomical factors involved in the lumbar region.

Authors:  L V Prabhu; V V Saralaya; M M Pai; A V Ranade; G Singh; S Madhyastha
Journal:  Osteoporos Int       Date:  2007-04-03       Impact factor: 5.071

2.  Cell-type-specific transcriptomics in chimeric models using transcriptome-based masks.

Authors:  Felix Naef; Joerg Huelsken
Journal:  Nucleic Acids Res       Date:  2005-07-19       Impact factor: 16.971

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.